Shannon T. Kelley - Aug 15, 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role: General Counsel
Signature: /s/ Mardi Dier, as Attorney-in-Fact
Stock symbol: MDGL
Transactions as of: Aug 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 8/19/2024, 08:16 PM
Previous filing: Aug 15, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDGL	Common Stock	Award	$0	+5.22K	+188.47%	$0.00	7.98K	Aug 15, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDGL	Stock Option (Right to Buy)	Award	$0	+7.82K		$0.00	7.82K	Aug 15, 2024	Common Stock	7.82K	$244.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units, which vest as to 25% of the shares on each of August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028, provided the Reporting Person continues in service with the Issuer on each such date.
F2	The option vests as to 25% of the shares on the first anniversary of the date of grant (August 15, 2025) and, thereafter, 6.25% of the shares shall vest on each quarterly anniversary following the first anniversary, provided the Reporting Person continues in service with the Issuer on each such date.